| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 740357 | Null | 0.0237269271456697 | 0.019803818 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.0237269271456697 | 0.37844871 |
| NSC 743695 | Null | 0.0237269271456697 | 0.27021612 |
| NSC 744688 | Null | 0.0237269271456697 | 0.50918334 |
| NSC 750050 | Null | 0.0237269271456697 | 0.1595266 |
| NSC 753377 | 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine | 0.0237269271456697 | 0.28397678 |
| NSC 753598 | Null | 0.0237269271456697 | 0.079537261 |
| NSC 761822 | (Z)-3-((1-(4-fluorophenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one | 0.0237269271456697 | 0.12171053 |
| NSC 762901 | trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide | 0.0237269271456697 | 0.45106746 |
| NSC 762908 | 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one | 0.0237269271456697 | 0.21889203 |